Molecular Diagnostic Platforms

State of Laboratory Technology 2019 - Vol. 8 No. 10 - Page #40

The flourishing field of molecular diagnostics enjoys a deep marketplace for automation platforms and testing selection. With clinical validity and utility remaining key to widespread implementation, the ongoing collaboration between clinical providers and laboratorians in determining both the appropriateness of molecular testing and, perhaps more important, the interpretation of the results of that testing, is essential to the promise of personalized medicine. As technological advances in molecular diagnostics continue with the exciting utilization of next generation sequencing (NGS) and digital polymerase chain reaction (dPCR) platforms, clinical laboratories will benefit from rapid translation of established and emerging molecular tests. 

An encouraging number of facilities of all sizes currently employ some type of molecular diagnostics instrumentation.

Cepheid and BioFire Diagnostics stand out in this busy market with numerous options.

Click here to view a larger version of this Chart





Like what you've read? Please log in or create a free account to enjoy more of what has to offer.

Current Issue

Enter our Sweepstakes now for your chance to win the following prizes:

Just answer the following quick question for your chance to win:

To continue, you must either login or register: